HOOKIPA Pharma Files 8-K on Security Holder Vote Matters
Ticker: HOOK · Form: 8-K · Filed: Jul 29, 2025 · CIK: 1760542
| Field | Detail |
|---|---|
| Company | Hookipa Pharma Inc. (HOOK) |
| Form Type | 8-K |
| Filed Date | Jul 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
HOOKIPA Pharma is holding a shareholder vote, details to come.
AI Summary
HOOKIPA Pharma Inc. filed an 8-K on July 29, 2025, to report on the submission of matters to a vote of security holders. The filing does not contain specific details about the matters to be voted on or any associated financial implications.
Why It Matters
This filing indicates that HOOKIPA Pharma Inc. is seeking approval from its security holders for certain corporate actions, which could impact the company's future direction.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose specific risks or material events.
Key Players & Entities
- HOOKIPA Pharma Inc. (company) — Registrant
- July 29, 2025 (date) — Date of earliest event reported
FAQ
What specific matters are being submitted for a vote of HOOKIPA Pharma Inc.'s security holders?
The filing does not specify the exact matters to be voted on, only that they are being submitted for security holder approval.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on July 29, 2025.
What is HOOKIPA Pharma Inc.'s principal executive office address?
The principal executive office is located at 350 Fifth Avenue, 72nd Floor, Suite 7240, New York, New York, 10118.
What is HOOKIPA Pharma Inc.'s telephone number?
The company's telephone number is +43 1 890 63 60.
What is the SEC file number for HOOKIPA Pharma Inc.?
The SEC file number for HOOKIPA Pharma Inc. is 001-38869.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 29, 2025 regarding HOOKIPA Pharma Inc. (HOOK).